Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Lexaria Announces Oral Nicotine Study NIC-A21-1 Results; Says 'DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls'


Benzinga | Oct 5, 2021 09:31AM EDT

Lexaria Announces Oral Nicotine Study NIC-A21-1 Results; Says 'DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls'






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC